Nicolas Roelofs

Nicolas Roelofs

Direktor/Vorstandsmitglied bei SEER, INC.

Vermögen: 49 847 $ am 31.05.2026

68 Jahre
Health Technology
Finance
Commercial Services

Profil

Nicolas Henry Roelofs is currently Chairman at Accelerate Technologies Pte Ltd., Director at LGC-Group LLC, Axion BioSystems, Inc., Hytest Oy, Thermo Fisher Scientific Blade I Ltd., and Biopath Ventures.
He is Non-Executive Director at LGC Ltd. since 2016, Director at One BioMed Pte Ltd. since 2017, Director at M51 Topco, Inc. since 2022, and Lead Independent Director at Seer, Inc. (California) since 2024.
Former roles include Chairman at BlueBee Holding BV (2016–2020), Scale Biosciences, Inc. (2021–2025), and Sengenics Corp.
LLC (2020–2024).
Served as Vice Chairman and Director at Embracing Future Holdings Ltd., Director at M51 Topco, Inc. (2022–2025), Independent Director at Boreal Genomics, Inc. (2014–2021), Director at Life Technologies Clinical Services Lab, Inc. (1997–2001), The Binding Site Group Ltd. (2014–2023), InSilixa, Inc. (2015–2021), Clear Labs, Inc. (2014–2019), DA32 Life Science Tech Acquisition Corp.
(2021–2023), and Board Member at SeraCare Life Sciences, Inc. (2014–2018).
Held positions at LGC Science Group Holdings Ltd., Olink Holding AB, and Summa Equity AB. Worked at Bio-Rad Laboratories, Inc. as Operations Officer-Life Sciences Group (2006), Agilent Technologies, Inc. as President-Life Sciences Group & Senior VP (2012–2013), Stratagene Corp.
as Chief Operating Officer (2004), and Baxter International, Inc. as Development Manager (1989–1997).
Education includes a doctorate from The University of Nevada, Reno (1987), a graduate degree from Iowa State University (1983), and an undergraduate degree from Simpson College (1979).

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.03.2026 26 656 ( 0,05 % ) 49 847 $ 31.05.2026

Aktive Positionen von Nicolas Roelofs

UnternehmenPositionBeginn
SEER, INC. Direktor/Vorstandsmitglied 13.08.2024
Direktor/Vorstandsmitglied -
Private Equity Investor -
Direktor/Vorstandsmitglied -
Vorsitzender -
Direktor/Vorstandsmitglied 01.07.2022
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.07.2017
Direktor/Vorstandsmitglied 01.04.2016
░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░ ░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Ehemalige bekannte Positionen von Nicolas Roelofs

UnternehmenPositionEnde
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Nicolas Roelofs im Detail an

Ausbildung von Nicolas Roelofs

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

83

Beziehungen ersten Grades

32

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen32

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Services

Commercial Services

Commercial Services

Health Technology

Consumer Services

Electronic Technology

Consumer Non-Durables

Health Technology

Finance

Miscellaneous

Health Technology

Health Technology

Commercial Services

Health Services

Finance

Health Technology

Health Technology

Finance

Sengenics Corp LLC

Technology Services

  1. Börse
  2. Insiders
  3. Nicolas Roelofs
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT